SELF-MONITORING BLOOD GLUCOSE MARKET - GROWTH, TRENDS, COVID-19 IMPACT, and Forecasts (2023 - 2028)

The Self-monitoring Blood Glucose Market is segmented by Component (Glucometer Devices, Test Strips, and Lancets) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The report offers the value (in USD million) for the above segments.

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Diabetes Drugs & Devices right-chevron-icon Self-Monitoring Blood Glucose Market

Self-Monitoring Blood Glucose Market Size

Self-monitoring Blood Glucose Market Summary
Study Period: 2018 - 2028
Fastest Growing Market: North America
Largest Market: North America
CAGR: > 6 %

Major Players

Self-monitoring Blood Glucose Market Major Players

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and it's growth?

Self-Monitoring Blood Glucose Market Analysis

The self-monitoring blood glucose market is set to witness a CAGR of more than 6%, during the forecast period 2022-2027 and is estimated to reach around USD 17 billion by 2027. North America holds the highest market share in the self-monitoring blood glucose market and is expected to register the highest CAGR of more than 7% in the forecast period.

The COVID-19 pandemic positively impacted the self-monitoring blood glucose market growth. Patients with diabetes, infected with COVID-19 may experience elevated blood glucose, abnormal glucose variability, and diabetic complications. To avoid aggravation, a patient's blood glucose monitoring should be monitored during the COVID-19 emergency which has underlined the importance of self-monitoring blood glucose devices.

The US Food and Drug Administration has also allowed the use of personal blood glucose meters and continuous glucose monitoring devices in hospitals for the duration of the pandemic. Pandemic emergency has created a rise in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the self-monitoring blood glucose market's growth globally.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 is approximately 537 million, and this number is going to increase by 643 million in 2030. The main diagnosis for diabetes patients is imbalances in blood glucose levels, which are not in compliance with the standard blood glucose levels. The general lab diagnostic tests can only help to diagnose the disease by physicians. Patients with more fluctuations in glucose levels need to get it checked every day. Patients administering insulin need to check their blood glucose levels frequently, adjust the doses of insulin, or change the medication, if necessary, which is only possible with the use of self-monitoring blood glucose devices.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Self-Monitoring Blood Glucose Industry Segmentation

Self-monitoring blood glucose (SMBG) is an important aid in diabetes mellitus care. Patients with diabetes can measure their blood glucose to detect hypoglycemia and adjust the insulin doses as needed and establish the response to nutrition and pharmacotherapy. The Self-monitoring Blood Glucose Market is segmented by Component (Glucometer Devices, Test Strips, and Lancets) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The report offers the value (in USD million) for the above segments.

Self-monitoring blood glucose devices
By Component (Value, and Volume, 2016-2027)
Glucometer Devices
Test Strips
Lancets
Geography
North America
United States (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Canada (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, Lancets)
Rest of North America (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Europe
France (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Germany (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Italy (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Spain (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
United Kingdom (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Russia (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Europe (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Latin America
Mexico (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Brazil (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Latin America (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Asia-Pacific
Japan (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
South Korea (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
China (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
India (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Australia (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Vietnam (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Malaysia (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Indonesia (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Philippines (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Thailand (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Asia-Pacific (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Middle-East and Africa
Saudi Arabia (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Iran (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Egypt (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Oman (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
South Africa (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Middle-East and Africa (Value, and Volume, 2016-2027)
By Component (Glucometer Devices, Test Strips, and Lancets)

Report scope can be customized per your requirements. Click here.

Self-Monitoring Blood Glucose Market Trends

This section covers the major market trends shaping the Self-Monitoring Blood Glucose Market according to our research experts:

Test strips Hold Highest Market Share in 2021

Test strips hold the highest market share of about 78% as of 2021. The growth in market volume and share of test strips are expected to be higher than that of glucose meters, because of the difference in use-case frequency. The Glucometer is a one-time purchase. However, test strips, on the other hand, are a continuous investment, as a test strip needs to be disposed of after one use. However, test strips, on the other hand, are a continuous investment. Thus, it presents a considerable cost impact to the consumers. Overall, the global demand for blood glucose test strips is projected to witness significant growth over the forecast period. The growth of the market studied is expected to be spurred by the rising global diabetic population. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame, the corresponding use of multiple (in the range of thousands) test strips may occur, causing a recurrent cost impact.

The COVID-19 pandemic emphasizes the need for good glycemic control in patients with diabetes, in large part because most observational studies have reported that poorly controlled diabetes is associated with a higher risk for hospitalization and death from a viral illness. Globally, diabetes mellitus has been of wide concern with its high global prevalence, resulting in increased financial burdens for clinical systems, individuals, and governments.

The market players are adopting various strategies such as collaborations, partnerships, mergers, acquisitions, and expansions to increase market share. For instance, in May 2021, Roche Diabetes Care Canada announces a collaboration with Ellerca Health, a Toronto-based company dedicated to improving patient care through innovation and technology. The partnership will include the launch of Accu-Chek and 360Care, combining Roche's Accu-Chek Guide blood glucose meter, customized home delivery of testing strips, and Ellerca's self-management digital program, 360Care, which empowers patients to be in control of their treatment schedule with access to a team of health coaches.

Thus, owing to the above-mentioned factors it is expected to drive the segment growth over the forecast period.

Self-monitoring Blood Glucose Market: Self-monitoring Blood Glucose Market: Type-2 diabetes population in million, Global, 2016-2021

North America is Expected to Dominate the Self-monitoring Blood Glucose Market

North America holds the highest market share in the Self-monitoring Blood Glucose Market and is also expected to register the highest CAGR of more than 7% in the forecast period.

The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure in the United States indicate the increasing usage of Self-monitoring Blood Glucose devices. North America is expected to dominate the market owing to factors such as the easy availability of Self-monitoring Blood Glucose, high awareness among consumers, and reimbursement policies.

In North America, there are more than 30 million diabetic patients, and this number is expected to increase to 34 million by 2027. The United States alone recorded over 26 million diabetes patients in 2021. The prevalence of diabetes has increased dramatically during the past two decades in North America, which is a fact driven by the increased prevalence of obesity and lifestyle changes. There is more carbohydrate consumption among the countries in the region, which is also one of the leading causes of obesity. In North America, the US is one of the countries with fast-growing chronic diseases and is the largest demand-generating country for Self-monitoring Blood Glucose Devices.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Self-monitoring Blood Glucose Market: Growth Rate By Region, 2021

Self-Monitoring Blood Glucose Industry Overview

The self-monitoring blood glucose market is consolidated, with a few major manufacturers having a global market presence and occupying a major share like Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia, while the remaining confined to the other local or region-specific manufacturers. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known.

Self-Monitoring Blood Glucose Market Leaders

  1. Lifescan

  2. Ascensia

  3. Arkray

  4. F. Hoffmann-La Roche AG

  5. Abbott Diabetes Care

*Disclaimer: Major Players sorted in no particular order

Self-monitoring Blood Glucose Market Concentration

Self-Monitoring Blood Glucose Market News

  • In June 2022, LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) has published Real World Evidence of Improved Glycemic Control in People with Diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter – synced via Bluetooth wireless technology – could support improved glycemic control for people with diabetes.
  • In Aug 2021, FIND, announced that agreements have been signed with i-SENS, Inc (Seoul, South Korea) and SD BIOSENSOR, Inc (Suwon-si, South Korea), to increase low- and middle-income countries’ (LMIC) access to blood glucose test strips by improving affordability.

Self-Monitoring Blood Glucose Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring blood glucose devices

      1. 5.1.1 By Component (Value, and Volume, 2016-2027)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value, and Volume, 2016-2027)

          1. 5.2.1.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.1.2 Canada (Value, and Volume, 2016-2027)

          1. 5.2.1.2.1 By Component (Glucometer Devices, Test Strips, Lancets)

        3. 5.2.1.3 Rest of North America (Value, and Volume, 2016-2027)

          1. 5.2.1.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      2. 5.2.2 Europe

        1. 5.2.2.1 France (Value, and Volume, 2016-2027)

          1. 5.2.2.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.2.2 Germany (Value, and Volume, 2016-2027)

          1. 5.2.2.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.2.3 Italy (Value, and Volume, 2016-2027)

          1. 5.2.2.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.2.4 Spain (Value, and Volume, 2016-2027)

          1. 5.2.2.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.2.5 United Kingdom (Value, and Volume, 2016-2027)

          1. 5.2.2.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.2.6 Russia (Value, and Volume, 2016-2027)

          1. 5.2.2.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        7. 5.2.2.7 Rest of Europe (Value, and Volume, 2016-2027)

          1. 5.2.2.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico (Value, and Volume, 2016-2027)

          1. 5.2.3.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.3.2 Brazil (Value, and Volume, 2016-2027)

          1. 5.2.3.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.3.3 Rest of Latin America (Value, and Volume, 2016-2027)

          1. 5.2.3.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan (Value, and Volume, 2016-2027)

          1. 5.2.4.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.4.2 South Korea (Value, and Volume, 2016-2027)

          1. 5.2.4.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.4.3 China (Value, and Volume, 2016-2027)

          1. 5.2.4.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.4.4 India (Value, and Volume, 2016-2027)

          1. 5.2.4.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.4.5 Australia (Value, and Volume, 2016-2027)

          1. 5.2.4.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.4.6 Vietnam (Value, and Volume, 2016-2027)

          1. 5.2.4.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        7. 5.2.4.7 Malaysia (Value, and Volume, 2016-2027)

          1. 5.2.4.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        8. 5.2.4.8 Indonesia (Value, and Volume, 2016-2027)

          1. 5.2.4.8.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        9. 5.2.4.9 Philippines (Value, and Volume, 2016-2027)

          1. 5.2.4.9.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        10. 5.2.4.10 Thailand (Value, and Volume, 2016-2027)

          1. 5.2.4.10.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        11. 5.2.4.11 Rest of Asia-Pacific (Value, and Volume, 2016-2027)

          1. 5.2.4.11.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia (Value, and Volume, 2016-2027)

          1. 5.2.5.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.5.2 Iran (Value, and Volume, 2016-2027)

          1. 5.2.5.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.5.3 Egypt (Value, and Volume, 2016-2027)

          1. 5.2.5.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.5.4 Oman (Value, and Volume, 2016-2027)

          1. 5.2.5.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.5.5 South Africa (Value, and Volume, 2016-2027)

          1. 5.2.5.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.5.6 Rest of Middle-East and Africa (Value, and Volume, 2016-2027)

          1. 5.2.5.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2016-2027)

    2. 6.2 Type-2 Diabetes Population (2016-2027)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Medisana

      10. 7.1.10 Trivida

      11. 7.1.11 Rossmax

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Abbott

      2. 7.2.2 Ascensia

      3. 7.2.3 F. Hoffmann-La Roche AG

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Self-Monitoring Blood Glucose Market Research FAQs

The Self-Monitoring Blood Glucose Market is studied from 2018 - 2028.

The Self-Monitoring Blood Glucose Market is growing at a CAGR of >6% over the next 5 years.

The Self-Monitoring Blood Glucose Market is valued at 12 Billion USD in 2018.

The Self-Monitoring Blood Glucose Market is valued at 17 Billion USD in 2028.

North America is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Lifescan, Ascensia, Arkray, F. Hoffmann-La Roche AG, Abbott Diabetes Care are the major companies operating in Self-Monitoring Blood Glucose Market.

Self-Monitoring Blood Glucose Industry Report

Statistics for the 2023 Self-Monitoring Blood Glucose market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Self-Monitoring Blood Glucose analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!